Literature DB >> 23113646

The vitreous humor as a barrier to nanoparticle distribution.

Jenifer Mains1, Clive G Wilson.   

Abstract

The vitreous humor represents a significant barrier to the penetration of nanoparticulate-based ocular drug delivery systems. The gel structure and biochemical components of the vitreous will impact the rate of nanoparticle movement through the tissue to reach the retinal tissue. Also the structure of the vitreous, flow systems operating within it, age-related structural changes, and the presence of inflammation will also have a potential effect on movement. To effectively target the posterior retina, the physical properties of the nanoparticle formulation are a key element in the design of a system that will penetrate through the vitreous barrier.

Entities:  

Mesh:

Year:  2012        PMID: 23113646     DOI: 10.1089/jop.2012.0138

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  9 in total

1.  ISOPT Clinical Hot Topic Panel Discussion on Ocular Drug Delivery.

Authors:  Uday B Kompella; Abraham Domb; Arto Urtti; Ashwath Jayagopal; Clive G Wilson; Diane Tang-Liu
Journal:  J Ocul Pharmacol Ther       Date:  2019-06-28       Impact factor: 2.671

2.  MEASUREMENT OF THE HYDRAULIC CONDUCTIVITY OF THE VITREOUS HUMOR.

Authors:  Anita N Penkova; Shuqi Zhang; Mark S Humayun; Scott Fraser; Rex Moats; Satwindar Singh Sadhal
Journal:  J Porous Media       Date:  2020       Impact factor: 1.663

Review 3.  Polysaccharides in Ocular Drug Delivery.

Authors:  Natallia Dubashynskaya; Daria Poshina; Sergei Raik; Arto Urtti; Yury A Skorik
Journal:  Pharmaceutics       Date:  2019-12-24       Impact factor: 6.321

Review 4.  Pars Plana Vitrectomy and the Risk of Ocular Hypertension and Glaucoma: Where Are We?

Authors:  Tommaso Rossi; Guido Ripandelli
Journal:  J Clin Med       Date:  2020-12-10       Impact factor: 4.241

5.  Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery.

Authors:  Natallia V Dubashynskaya; Anton N Bokatyi; Alexey S Golovkin; Igor V Kudryavtsev; Maria K Serebryakova; Andrey S Trulioff; Yaroslav A Dubrovskii; Yury A Skorik
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

6.  Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma.

Authors:  Elham Delrish; Fariba Ghassemi; Mahmoud Jabbarvand; Alireza Lashay; Fatemeh Atyabi; Masoud Soleimani; Rassoul Dinarvand
Journal:  J Ophthalmic Vis Res       Date:  2022-01-21

Review 7.  Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds.

Authors:  Malihe Sadat Razavi; Pedram Ebrahimnejad; Yousef Fatahi; Antony D'Emanuele; Rassoul Dinarvand
Journal:  Front Chem       Date:  2022-04-13       Impact factor: 5.545

8.  Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.

Authors:  Salma El-Sayed Radwan; Amal El-Kamel; Eiman I Zaki; Susi Burgalassi; Erica Zucchetti; Riham M El-Moslemany
Journal:  Int J Nanomedicine       Date:  2021-07-02

9.  Pullulan Based Bioconjugates for Ocular Dexamethasone Delivery.

Authors:  Eva Kicková; Stefano Salmaso; Francesca Mastrotto; Paolo Caliceti; Arto Urtti
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.